50 related articles for article (PubMed ID: 20960003)
1. Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia.
Roh S; Hoeppner SS; Schoenfeld D; Fullerton CA; Stoeckel LE; Evins AE
Psychopharmacology (Berl); 2014 Feb; 231(4):765-75. PubMed ID: 24114425
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting cholinergic signalling in the cerebellar interpositus nucleus impairs motor behaviour.
Pickford J; Iosif CI; Bashir ZI; Apps R
Eur J Neurosci; 2024 May; 59(9):2208-2224. PubMed ID: 37455360
[TBL] [Abstract][Full Text] [Related]
3. Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition.
Johnson CR; Kangas BD; Jutkiewicz EM; Winger G; Bergman J; Coop A; Woods JH
J Pharmacol Exp Ther; 2021 Jun; 377(3):336-345. PubMed ID: 33712507
[TBL] [Abstract][Full Text] [Related]
4. The limbic-reticular coupling theory of memory processing in the brain and its greater compatibility over other theories.
Cai ZJ
Dement Neuropsychol; 2018; 12(2):105-113. PubMed ID: 29988336
[TBL] [Abstract][Full Text] [Related]
5. Scopolamine disrupts place navigation in rats and humans: a translational validation of the Hidden Goal Task in the Morris water maze and a real maze for humans.
Laczó J; Markova H; Lobellova V; Gazova I; Parizkova M; Cerman J; Nekovarova T; Vales K; Klovrzova S; Harrison J; Windisch M; Vlcek K; Svoboda J; Hort J; Stuchlik A
Psychopharmacology (Berl); 2017 Feb; 234(4):535-547. PubMed ID: 27885411
[TBL] [Abstract][Full Text] [Related]
6. Interaction of basal forebrain cholinergic neurons with the glucocorticoid system in stress regulation and cognitive impairment.
Paul S; Jeon WK; Bizon JL; Han JS
Front Aging Neurosci; 2015; 7():43. PubMed ID: 25883567
[TBL] [Abstract][Full Text] [Related]
7. Effect of cholinergic neurotransmission modulation on visual spatial paired associate learning in healthy human adults.
Harel BT; Pietrzak RH; Snyder PJ; Maruff P
Psychopharmacology (Berl); 2013 Aug; 228(4):673-83. PubMed ID: 23568575
[TBL] [Abstract][Full Text] [Related]
8. Cholinergic blockade under working memory demands encountered by increased rehearsal strategies: evidence from fMRI in healthy subjects.
Voss B; Thienel R; Reske M; Kellermann T; Sheldrick AJ; Halfter S; Radenbach K; Shah NJ; Habel U; Kircher TT
Eur Arch Psychiatry Clin Neurosci; 2012 Jun; 262(4):329-39. PubMed ID: 22006639
[TBL] [Abstract][Full Text] [Related]
9. Review of pharmacological treatment in mood disorders and future directions for drug development.
Li X; Frye MA; Shelton RC
Neuropsychopharmacology; 2012 Jan; 37(1):77-101. PubMed ID: 21900884
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans.
Ellis JR; Ellis KA; Bartholomeusz CF; Harrison BJ; Wesnes KA; Erskine FF; Vitetta L; Nathan PJ
Int J Neuropsychopharmacol; 2006 Apr; 9(2):175-89. PubMed ID: 15877932
[TBL] [Abstract][Full Text] [Related]
11. Role of central cholinergic receptor sub-types in spatial working memory: a five-arm maze task in mice provides evidence for a functional role of nicotinic receptors in mediating trace access processes.
Maviel T; Durkin TP
Neuroscience; 2003; 120(4):1049-59. PubMed ID: 12927210
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review.
Drevets WC; Zarate CA; Furey ML
Biol Psychiatry; 2013 Jun; 73(12):1156-63. PubMed ID: 23200525
[TBL] [Abstract][Full Text] [Related]
13. Cognitive performance and cholinergic transmission: influence of muscarinic and nicotinic receptor blockade.
Voss B; Thienel R; Reske M; Habel U; Kircher T
Eur Arch Psychiatry Clin Neurosci; 2010 Nov; 260 Suppl 2():S106-10. PubMed ID: 20960003
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans.
Green A; Ellis KA; Ellis J; Bartholomeusz CF; Ilic S; Croft RJ; Phan KL; Nathan PJ
Pharmacol Biochem Behav; 2005 Jul; 81(3):575-84. PubMed ID: 15936063
[TBL] [Abstract][Full Text] [Related]
15. An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine.
Baakman AC; Alvarez-Jimenez R; Rissmann R; Klaassen ES; Stevens J; Goulooze SC; den Burger JCG; Swart EL; van Gerven JMA; Groeneveld GJ
Br J Clin Pharmacol; 2017 Aug; 83(8):1676-1687. PubMed ID: 28217868
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
